semaglutide and tirzepatide weight loss for Tirzepatide vs Semaglutide: 2026 Clinical

A note on perspective and our clinical model: Im Eli Luft, PA-C, COO of Rivas Medical Weight Loss

Many clinics do stack GLP-1 medications with other peptides for example, pairing tirzepatide with BPC-157 for patients who experience joint pain as they lose weight, or with CJC-1295 and Ipamorelin for muscle preservation

Adverse Ocular Changes : Patients who have experienced significant vision changes or diagnosed ocular conditions while receiving Zepbound therapy should consider the following actions: Document all medical records related to vision problems, including ophthalmological evaluations, diagnostic imaging, and treatment interventions Establish temporal relationship between medication initiation or dose escalation and symptom onset Consult with legal counsel specializing in pharmaceutical litigation to evaluate case viability Report adverse events to the FDA MedWatch program to contribute to pharmacovigilance databases Preserve evidence of medication packaging, prescription records, and healthcare provider communications Evolving Litigation Landscape: The evolving litigation landscape surrounding tirzepatide underscores the necessity for transparent risk disclosure and comprehensive patient counseling regarding potential ocular complications

For commercially insured patients whose plans cover the medication, copay assistance can reduce out-of-pocket costs to $25 per month

However, ongoing vomiting or symptoms lasting more than a few days should be discussed with a medical professional, as a treatment review or temporary dose adjustment may be needed